Amgen Misses on EPS, Guides Above



Amgen (AMGN) reported fourth quarter 2012 earnings of $1.39 per share, 4 cents below the Zacks Consensus Estimate. Earnings, however, increased 16.8% from the year-ago period. Higher revenues and a lower share count contributed to the year-over-year increase in earnings.

Total revenue increased 11.0% to $4,421 million in the fourth quarter of 2012, comfortably surpassing the Zacks Consensus Estimate of $4,371 million. Key growth drivers included Enbrel, Xgeva, and Prolia.

Including one-time items, fourth quarter earnings declined 6% to $1.01 per share.

Full year earnings increased 22.6% to $6.45 per share, missing the Zacks Consensus Estimate of $6.49. Total revenues increased 11% to $17,265 million, surpassing the Zacks Consensus Estimate of $17,215 billion.

The Quarter in Detail

Fourth quarter total product revenues increased 11% to $4,337 million (US: $3,315 million, ex-US: $1,022 million).

Revenues of Amgen’s erythropoiesis-stimulating agent (ESA) Aranesp fell 9% to $489 million (US: $187 million; ex-US: $302 million) due to changes in practice patterns.

Revenues of Amgen’s other ESA, Epogen, decreased 1% to $479 million mainly due to a reduction in dose utilization that offset the impact of lower customer discounts and a favorable change in accounting estimates. Revenues declined 2% sequentially due to competition. We note that a new competitor, Affymax’ (AFFY) Omontys (peginesatide), has entered the dialysis market. On its fourth quarter call, Amgen said that the impact of competition continues to be modest and mainly in the form of pilot programs.

Worldwide revenues of Neulasta and Neupogen declined 1% to $1,306 million in the fourth quarter. Amgen is focusing on increasing investment in the US on direct-to-patient and caregiver communications in order to increase awareness about the risk of febrile neutropenia.

Enbrel delivered revenues of $1,161 million, up 23%. Higher average net sales price and increase in unit demand drove revenues. The company has been taking steps to improve Enbrel’s performance which includes optimization of the sales force, higher direct-to-consumer advertising and increased focus on appropriate access.

The company said that it has been increasing its share among bio-naïve (patients new to biologics) patients. With Amgen and Pfizer’s (PFE) collaboration for Enbrel set to expire in late 2013, Amgen has completed the consolidation of US field sales activities under its wing. The consolidated sales force is targeting both the rheumatology and dermatology segments.

Fourth quarter 2012 Prolia revenues came in at $154 million, up from third quarter 2012 revenues of $110 million.

Meanwhile, Xgeva, which gained FDA approval in Nov 2010, delivered fourth quarter 2012 revenues of $215 million, up from the $201 million, $179 million, and $153 million reported in the last three quarters. Xgeva’s unit share in the US increased to 37% in the fourth quarter. However, with Novartis’ (NVS) Zometa slated to lose patent protection, there could some choppiness in the market with the entry of generic competition and reimbursement considerations.

Sensipar/Mimpara revenues increased 19% to $256 million in the reported quarter. Vectibix revenues came in at $91 million during the quarter, up 5%.

While fourth quarter 2012 R&D expenses increased 9% from the year-ago period, SG&A expenses increased 13%. Higher Enbrel profit share expenses and expansion in international markets led to the increase.

Amgen bought back 14 million shares during the reported quarter for $1.2 billion. Going forward, the company expects its share buyback activities to slow down with a higher focus on increasing dividend meaningfully.

Guides above Expectations

The company expects to earn $6.85 - $7.15 (up 5-10% from 2012) per share on total revenues of $17.8 billion - $18.2 billion (up 3-5% from 2012). Guidance was above expectations with the Zacks Consensus Estimate for earnings and revenues standing at $6.78 per share and $17.7 billion, respectively.

The company also provided an update on its 2015 guidance which had initially been provided in 2011. Amgen, which had forecasted 2015 earnings of $7.25 to $8.60 per share on revenues of $16 billion - $18 billion, now expects to reach the upper end of its revenue guidance in 2013 itself. Meanwhile, the company expects to achieve the earnings guidance in 2014.

During 2015, the company expects to achieve at least the upper end of its revenue guidance range and deliver earnings per share of at least $8.00.

Amgen currently carries a Zacks Rank #3 (Hold). We expect investor focus to remain on the company’s business review on Feb 7.

While both Pfizer and Novartis are Zacks Rank #3 stocks, Affymax is a Zacks Rank #2 stock (Buy).

Read the Full Research Report on PFE

Read the Full Research Report on AMGN

Read the Full Research Report on NVS

Read the Full Research Report on AFFY

Zacks Investment Research

More From


Get stories like this on the Yahoo app and discover more every day.
Download it now.
  • Turkish tanks enter Syrian territory to fight IS
    Turkish tanks enter Syrian territory to fight IS AFP News - 8 minutes ago

    A dozen Turkish tanks on Wednesday entered Syrian territory to take part in the battle to push Islamic State (IS) jihadists out of the town of Jarabulus, an AFP photographer reported. … More »

  • Biden in Ankara as Turkey launches Syria operation
    Biden in Ankara as Turkey launches Syria operation AFP News - 12 minutes ago

    US Vice President Joe Biden arrived in Turkey on Wednesday for critical talks with its leadership as Ankara launched a military operation to drive Islamic State jihadists out of a key Syrian border town. In the highest-ranking visit by a Western … More »

  • UK carpet seller Headlam ups prices after post-Brexit sterling weakness Reuters - 16 minutes ago

    British carpet distributor Headlam (HEAD.L) has raised its prices after a weaker pound in the wake of the Brexit vote pushed up the cost of imports from continental Europe, showing the potential inflationary impact of sterling's decline. Headlam, … More »

  • Oil prices down in Asia, Brent stays below $50 AFP News - 17 minutes ago

    Oil fell in Asia Wednesday on oversupply fears, after data showed an increase in US crude stocks, and as traders took advantage of a recent rally to book profits. Prices had closed higher Tuesday on news that Iran was willing to join calls by OPEC … More »

  • Commodities group Glencore trims loss in first half of 2016 Associated Press - 29 minutes ago

    Swiss commodities producer Glencore says it narrowed its net loss in the first half of 2016, after paring down billions of dollars' worth of assets to slash debt amid a difficult market for raw materials. ... … More »

  • Foundation donors who met, talked with Clinton Associated Press - 32 minutes ago

    Hillary Clinton met or talked by phone with at least 154 people from private interests, such as corporations, during her time as secretary of the state. More than half those people had donated either personally ... … More »

  • US oil and gas lease sale to be broadcast live on internet
    US oil and gas lease sale to be broadcast live on internet Associated Press - 40 minutes ago

    The federal government says that, for the first time, it's broadcasting an oil and gas lease sale live on the internet. The sale Wednesday offers all 23.8 million acres available for drilling and exploration ... … More »

  • Asian markets struggle, oil losses widen on glut woe
    Asian markets struggle, oil losses widen on glut woe AFP News - 6 minutes ago

    Most Asian markets slipped Wednesday as traders trod water ahead of a key speech by Federal Reserve boss Janet Yellen this week, while oil suffered fresh losses on persistent glut worries. With speculation growing that US interest rates could rise … More »

  • Australian carrier Qantas soars to record profits
    Australian carrier Qantas soars to record profits AFP News - 55 minutes ago

    Australian carrier Qantas Wednesday posted record annual profits and announced its first payout to shareholders in seven years, staging a turnaround after axing jobs and selling aircraft in an aggressive restructuring. The results were also boosted … More »

  • Asian stocks meander as investors await Fed speech; Oil down
    Asian stocks meander as investors await Fed speech; Oil down Associated Press - 56 minutes ago

    Asian stocks meandered Wednesday as investors awaited fresh cues from Federal Reserve on the outlook for interest rates. Markets were steady following the submarine launch of a ballistic missile by North ... … More »

  • CORRECTED: Australian carrier Qantas soars to record profits AFP - 1 hour 1 minute ago

    Australian carrier Qantas Wednesday posted record annual profits and announced its first payout to shareholders in seven years, staging a turnaround after axing jobs and selling aircraft in an aggressive ... … More »

  • European stocks slip at open AFP - 1 hour 12 minutes ago

    Europe's main stock markets fell at the start of trading on Wednesday, with London's benchmark FTSE 100 index down 0.6 percent to 6,838.35 points. Frankfurt's DAX 30 also lost 0.6 percent to 10,531.14 ... … More »

  • Emerging Assets Fall With Europe Shares as Fed Bets Boost Dollar Bloomberg - 1 hour 14 minutes ago

    Oil slumped after data showed a jump in U.S. stockpiles. MSCI gauges of developing nations’ shares and currencies dropped by the most in at least three weeks, while the Stoxx Europe 600 Index snapped a two-day advance. A gauge of dollar strength … More »

  • Samsung, Tencent surge in race to become Asia's most valuable firm
    Samsung, Tencent surge in race to become Asia's most valuable firm Reuters - 1 hour 19 minutes ago

    Tencent Holdings Ltd and Samsung Electronics Co Ltd are racing to be crowned Asia's most valuable company as expectations for robust earnings growth push their share prices to record highs. "These companies can grow earnings despite weaker global … More »

  • WPP beats first-half net sales forecasts, boosted by weak pound Reuters - 1 hour 22 minutes ago

    The group, run by high-profile businessman Martin Sorrell, said its British operations had also traded more strongly in July than the previous quarter which it said perhaps reflected a "post-Brexit vote recovery" driven by a weaker pound. WPP said … More »

  • Frankfurt charm offensive for Brexit-wary London firms
    Frankfurt charm offensive for Brexit-wary London firms AFP News - 1 hour 25 minutes ago

    The marketing team of Frankfurt never expected its English-language dummy website to attract new businesses would actually go live after Britain's European Union referendum. "We hadn't really assumed that we would need the site at all," spokeswoman … More »

  • Stressed pension funds urge UK to sell more inflation-proof debt Reuters - 1 hour 35 minutes ago

    Pension funds are pushing the British government to issue more index-linked bonds to insulate them from inflation and help cope with worrisome accounting deficits that have intensified since Britain voted in June to leave the European Union. The … More »

  • Glencore's underlying profit falls, lowers debt target
    Glencore's underlying profit falls, lowers debt target Reuters - 1 hour 40 minutes ago

    Glencore reported first-half adjusted underlying profit (EBITDA) down 13 percent at $4 billion (3.04 billion pounds), but said it was on track to sell assets and lowered its net debt target to between $16.5 billion and $17.5 billion this year. It … More »

  • OneSavings more keen on lending to professional landlords after Brexit Reuters - 1 hour 45 minutes ago

    OneSavings, which offers residential mortgages, buy-to-let and SME loans, said that while it was not directly exposed to the EU, its business could be hurt by a slowdown in the housing market and demand for mortgages, in case of an economic … More »

  • China’s $100 Billion Chip Supremacy Bid Deemed Unrealistic (1) Bloomberg - 1 hour 49 minutes ago

    China is one of the world’s largest consumers of semiconductor devices thanks to its manufacturing might, and is planning to spend more than $100 billion to become also a premier supplier to the planet. It’s also driven consolidation among domestic … More »

  • Oil prices fall on U.S. crude stocks build; fears over China demand
    Oil prices fall on U.S. crude stocks build; fears over China demand Reuters - 1 hour 50 minutes ago

    Oil prices fell on Wednesday as an unexpected build in U.S. crude inventories weighed on markets, along with concerns that Chinese crude demand could falter as Beijing clamps down on alleged tax evasion in the oil industry. International Brent … More »

  • North Korea Successfully Launches Ballistic Missile From Sub (1) Bloomberg - 2 hours 0 minutes ago

    The missile flew about 500 kilometers, suggesting the nation’s missile technology has improved from previous launches, a South Korean defense ministry official said. The projectile was fired at about 5:30 a.m. from waters near the city of Sinpo … More »

  • Glencore Profit Tumbles 66% After Metal and Coal Price Rout (1) Bloomberg - 2 hours 7 minutes ago

    Last year’s collapse in commodities and Glencore shares forced the firm to roll out a rescue strategy that included scrapping its dividend, selling $2.5 billion of stock, disposing of assets and slashing spending. Glencore earlier today announced a … More »

  • PBOC Adds Funds in 14-Day Reverse Repos First Time in Six Months Bloomberg - 2 hours 10 minutes ago

    The People’s Bank of China auctioned 50 billion yuan ($7.5 billion) of the contracts in open-market operations at 2.4 percent Wednesday, according to a statement on its website. The central bank also offered 90 billion yuan of seven-day reverse … More »

  • Automakers lead Tokyo stocks higher by close AFP - 2 hours 19 minutes ago

    Tokyo stocks finished higher Wednesday with the market led by strong gains among automakers including Toyota and rival Nissan. The benchmark Nikkei 225 index jumped 0.61 percent, or 99.94 points, to close ... … More »

Recent Quotes
Symbol Price Change % Chg 
Your most recently viewed tickers will automatically show up here if you type a ticker in the "Enter symbol/company" at the bottom of this module.
You need to enable your browser cookies to view your most recent quotes.
to view quotes in your portfolios.


  • Most Actives
    Most Actives
    NamePriceChange% Chg
  • % Gainers
    % Gainers
    NamePriceChange% Chg
  • % Losers
    % Losers
    NamePriceChange% Chg

Market Data

  • Currencies
    NamePriceChange% Chg
  • Commodities
    NamePriceChange% Chg
  • Bonds
    TreasuryYield (%)Yield Change